Olive Garden Facing Investor Pressure to Eliminate Antibiotics

September 29, 2016

Darden Restaurants, the nation’s largest restaurant company and owner of Olive Garden, is facing pressure from investors Thursday at its annual shareholder meeting to eliminate the routine use of antibiotics in its supply chain, a practice that can fuel the spread of drug resistant bacteria.

The shareholder proposal, presented by Green Century Capital Management, comes after Darden was sent a letter signed by a coalition of investors managing more than $1 trillion in assets that urged the company to end the routine use of antibiotics important to human medicine in its global meat and poultry supply chains. A similar letter